The synthetic TRPML1 agonist, ML-SA1, rescues Alzheimer-related alterations of the endosomal-autophagic-lysosomal system

First Author: Somogyi, A
Attributed to:  Therapeutic targeting of impaired lysosomal flux in Alzheimer's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Journal Article/Review

Parent Publication: Journal of Cell Science